2023
DOI: 10.3390/ijms25010560
|View full text |Cite
|
Sign up to set email alerts
|

Non-Coding RNAs as Key Regulators in Lung Cancer

Irina Gilyazova,
Galiya Gimalova,
Aigul Nizamova
et al.

Abstract: For several decades, most lung cancer investigations have focused on the search for mutations in candidate genes; however, in the last decade, due to the fact that most of the human genome is occupied by sequences that do not code for proteins, much attention has been paid to non-coding RNAs (ncRNAs) that perform regulatory functions. In this review, we principally focused on recent studies of the function, regulatory mechanisms, and therapeutic potential of ncRNAs including microRNA (miRNA), long ncRNA (lncRN… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 212 publications
0
4
0
Order By: Relevance
“…Lung cancer is the leading cause of cancer-related death worldwide, with NSCLC accounting for the majority of cases (up to 85%), and LUAD representing the most common NSCLC subtype. The contribution of ncRNAs to the onset and progression of LC is becoming increasingly clear, especially for microRNAs and lncRNAs [5]. In addition, the ceRNET perspective has opened a new scenario, wherein even functionally unrelated transcripts can unexpectedly cross talk with each other by competitively binding to a shared microRNA, and new functions have been assigned to molecules involved in distant and unrelated biological processes [13,14].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Lung cancer is the leading cause of cancer-related death worldwide, with NSCLC accounting for the majority of cases (up to 85%), and LUAD representing the most common NSCLC subtype. The contribution of ncRNAs to the onset and progression of LC is becoming increasingly clear, especially for microRNAs and lncRNAs [5]. In addition, the ceRNET perspective has opened a new scenario, wherein even functionally unrelated transcripts can unexpectedly cross talk with each other by competitively binding to a shared microRNA, and new functions have been assigned to molecules involved in distant and unrelated biological processes [13,14].…”
Section: Discussionmentioning
confidence: 99%
“…Recently, the role of non-coding RNAs in lung cancer appeared on the scene, particularly microRNAs (miRNAs), among the ncRNAs smaller than 200 nucleotides, and long non-coding RNAs (lncRNAs), with a size up to several kilobases [5]. It is becoming increasingly clear that they play a key role in lung cancer, by acting as oncogenes, triggering the molecular pathways leading to cancer onset and progression, but also as tumor suppressors, by braking the cancer hallmarks; in addition, they can even have a role in therapeutic responses such as chemoresistance [6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…Mounting evidence underscores the pivotal roles of exosomal lncRNAs and circRNAs in tumor progression, functioning as either oncogenes or suppressors [ 52 , 53 ]. These molecules facilitate key regulatory functions in cell-cell communication within the tumor microenvironment through mechanisms such as fusion, endocytosis, and receptor-mediated specific binding [ 54 ].…”
Section: Insights Into the Exosomal Lncrnas And Circrnasmentioning
confidence: 99%
“…miRNAs have been proved to be important factors in the development of cancer and are involved in various stages of cancer development, 6–8 such as apoptosis, 9 metastasis and invasion, 10 and angiogenesis. 11 The level of miRNA is dysregulated in the development of cancer.…”
Section: Introductionmentioning
confidence: 99%